Psyence Biomedical (PBM) Stock Statistics & Valuation Metrics

Psyence Biomedical has a market cap or net worth of $2.58M. The enterprise value is ―.

Psyence Biomedical has 583,263 shares outstanding. The number of shares has decreased by -2.65% in one year.

Psyence Biomedical’s return on equity (ROE) is 4.66 and return on invested capital (ROIC) is 524.51%.

The current PE Ratio of Psyence Biomedical is -10.89. Psyence Biomedical’s PEG ratio is ―.

In the last 12 months, Psyence Biomedical had revenue of 0.00 and earned -51.16M in profits. Earnings per share was -7.85.

In the last 12 months, operating cash flow was -1.05M and capital expenditures 0.00, giving a free cash flow of -801.65K billion.

Psyence Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

Psyence Biomedical upcoming earnings date is ―, TBA Not Confirmed.

Psyence Biomedical as a current ratio of 0.09, with Debt / Equity ratio of -199.26%

In the past 12 months, Psyence Biomedical has paid 0.00 in taxes.

Psyence Biomedical EV to EBITDA ratio is -206.03, with an EV/FCF ratio of -192.10.

Psyence Biomedical has $0.00 in cash and marketable securities with C$10.45K in debt, giving a net cash position of $10.45K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Psyence Biomedical is ―, which is 11.43% higher than the current price. The consensus rating is ―